Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Gland Pharma Ltd

Healthcare | Mid Cap

Gland Pharma Ltd Health Insights
Health Score : 7.91Health Score : 7.91

Gland Pharma Ltd. presents a picture of exceptional financial strength, marked by outstanding profitability and impressive growth. The company is extremely stable, operating with almost no debt, which makes it highly resilient to financial shocks. It is rapidly expanding its sales, profits, and assets, indicating a successful business strategy and strong market demand. Shareholders benefit from high earnings, a strong asset backing per share, and attractive dividends. However, there is a significant contrast in its operational efficiency. The company struggles to use its assets effectively to generate sales and is slow in selling inventory and collecting payments. This inefficiency is a notable weakness in an otherwise stellar financial profile. Looking ahead, while growth and profitability are expected to remain strong, the key challenge for the company will be translating its significant investments into more productive and efficient operations.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Gland Pharma Ltd Health Insights
Health Score : 7.91Health Score : 7.91

Gland Pharma Ltd. presents a picture of exceptional financial strength, marked by outstanding profitability and impressive growth. The company is extremely stable, operating with almost no debt, which makes it highly resilient to financial shocks. It is rapidly expanding its sales, profits, and assets, indicating a successful business strategy and strong market demand. Shareholders benefit from high earnings, a strong asset backing per share, and attractive dividends. However, there is a significant contrast in its operational efficiency. The company struggles to use its assets effectively to generate sales and is slow in selling inventory and collecting payments. This inefficiency is a notable weakness in an otherwise stellar financial profile. Looking ahead, while growth and profitability are expected to remain strong, the key challenge for the company will be translating its significant investments into more productive and efficient operations.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Overvalued

P/E RATIO (TTM)

27.88

Neutral

Industry Median

28.62

Neutral
Neutral

Mid Cap Median

36.34

Neutral

P/E RATIO

35.27

P/B RATIO

3.50

Neutral

Industry Median

3.17

Neutral
Undervalued

Mid Cap Median

7.64

Undervalued

P/S RATIO

5.64

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Neutral

Mid Cap Median

6.30

Neutral

Others

Overvalued

PEG RATIO

37.92

Overvalued
Overvalued

EV/EBITDA RATIO

17.19

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2199 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Concall Report3rd Feb 26

Q3 FY26 Earnings Conference Call

BULLISH SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is in a phase of exceptional growth. It is expanding its revenue, profits, and asset base at an outstanding rate. This rapid expansion across all key growth indicators points to strong market positioning, high demand for its products or services, and a successful strategy for scaling the business. This robust growth is a major strength and a key driver of value for the company.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate27.09-17.6356.28-0.8614.51
Operating Profit Growth Rate15.98-32.1230.05-4.828.45
Earnings Per Share (EPS) Growth21.02-35.7-1.1-9.5947.05
Asset Growth Rate20.612.0520.885.311.98
Net Income Growth Rate21.56-35.56-1.15-9.4646.92
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.40

The company's financial metrics reflect a very strong position for shareholders. Key indicators such as earnings per share (both adjusted and cash-based) and book value are excellent, demonstrating high profitability and intrinsic value. The company also offers a strong dividend. The only note of caution is the very high level of capital spending, which, while intended for growth, represents a significant use of cash.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
ExcellentDividend Per Share (DPS)Excellent
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)75.5651.3148.2543.6265.25
Cash Earnings Per Share (Cash EPS)82.625869.8167.3190.69
Book Value Per Share447.31497.38545.19571.88647.31
Dividend Per Share (DPS)0020.1717.8119.95
Capital Expenditures (CapEx)522223397394493
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is excellent. It demonstrates a superior ability to convert revenue into profit at every level, from gross margin to net margin. It also generates outstanding returns on the capital, equity, and assets it employs. This all-around strength in profitability indicates highly effective management, strong pricing power, and efficient cost control, making it a key highlight of the company's financial health.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin31.8124.2217.4415.8718.75
Return on Capital Employed (ROCE)2515141215
Return on Equity (ROE)16.939.818.857.649.92
Return on Assets (ROA)19.2711.6812.5611.3613.03
Operating Margin34.3128.2823.5322.625.35
Net Margin27.5421.5413.6312.4515.97
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.33

The company's operational efficiency is a significant area of concern. Across the board, key metrics show that the company struggles to use its assets—including fixed assets, inventory, and capital—to generate sales effectively. It also takes a long time to sell its products and collect payments from customers. This inefficiency represents a drag on performance and indicates a disconnect between the company's investments in assets and its revenue-generating capabilities.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.932.311.441.351.43
Inventory Turnover Ratio2.441.752.62.833.05
Receivables Turnover Ratio5.043.734.663.653.77
Days Sales in Inventory Ratio149.59208.57140.38128.98119.67
Receivable Days72.4297.8678.3310096.82
Capital Turnover Ratio0.610.460.640.610.61
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.40

The company's ability to cover its financial obligations is very strong. With earnings far exceeding its interest payments, there is virtually no risk of default on its debt. Furthermore, its profits provide a safe and sustainable cover for dividend payments to shareholders. This indicates a high degree of financial security and a reliable capacity to service both its debt and equity commitments.

ExcellentInterest Coverage RatioExcellent
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio324.8151.7144.5826.3145.39
Equity Dividend Coverage Ratio2.332.383.12
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency is outstanding, representing a position of maximum financial stability. The business operates with virtually no debt, financing its operations and growth almost entirely through equity. This extremely conservative financial structure means there is negligible risk of financial distress due to borrowing. This indicates a robust, self-reliant balance sheet that is highly resilient to economic downturns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio000.020.010.01
Debt to Equity Ratio000.020.010.01
Equity Ratio110.980.990.99
Debt To Asset Ratio000.010.010.01
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 9.20

The company's liquidity position is exceptionally strong. It possesses a very high capacity to meet its short-term financial obligations using its available assets. This is primarily driven by its substantial holdings of cash and other highly liquid assets. While cash generation from operations is average, the overall liquidity cushion is more than sufficient, indicating very low risk of short-term financial distress and providing significant operational flexibility.

ExcellentCurrent RatiosExcellent
ExcellentQuick RatiosExcellent
ExcellentCash RatiosExcellent
AverageOperating Cash Flow RatiosAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio8.928.633.723.623.76
Quick Ratio7.156.242.762.732.9
Cash Ratio4.614.631.061.351.64
Operating Cash Flow Ratio1.180.450.580.480.5
01.

Current Ratios

02.

Quick Ratios

03.

Cash Ratios

04.

Operating Cash Flow Ratios

Peer Comparison With 16 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
2J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
3Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
4Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
5Granules India Ltd7.7332.77Highly Overvalued1185.0016.17595.00
6Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
7Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
8Syngene International Ltd7.4456.08Overvalued918.007.55317.00
9Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
10ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
11Ipca Laboratories Ltd6.3335.26Neutral1979.0044.641184.00
12Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
13Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
14Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
15Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
16Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
Management Assessment Summary
OrangeBalanced Management

Management effectiveness for Gland Pharma presents a mixed picture. On the positive side, management demonstrates excellent financial prudence with negligible debt, a very strong interest coverage ratio, and the recent initiation of dividend payments. They also achieved a remarkable sales rebound in FY24. However, these strengths are overshadowed by significant operational weaknesses. There is a severe and persistent decline in profitability margins (OPM, NPM) and capital efficiency metrics (ROCE, ROE) over multiple years. The inability to translate strong sales growth into profit growth in FY24 is a major concern, pointing to challenges in cost control and operational efficiency.

Category Metric Value Assessment
PROS Strong Promoter Holding 57.86% Strong
Low Debt/Equity Ratio 0.04 Excellent
Strong Sales Growth (FY24) 56.29% Very Strong
Increasing DII Holding 25.23% Improving
CONS Declining Profitability (OPM) 24% (from 38%) Declining
Weak Capital Efficiency (ROCE) 14% (from 28%) Declining
High Cash Conversion Cycle 250 Days Weak
Disconnect in Sales vs. Profit -6% Profit Growth Inconsistent
WeakFinancial Performance & GrowthWeak
PoorCapital Efficiency & ReturnsPoor
ExcellentFinancial Health & PrudenceExcellent
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The overall risk profile reflects a significant disparity between operational risk and financial risk. The primary concern is operational, stemming from deteriorating profitability and efficiency. The inability to convert a 56% sales growth into profit growth in FY24 is a major red flag, highlighting severe cost pressures. This trend of declining margins and returns (ROCE, ROE) constitutes a material risk to future value creation. However, this high operational risk is partially mitigated by an extremely low financial risk profile. The company is virtually debt-free, which provides a substantial buffer and financial flexibility to navigate operational challenges.

WeakOperational Cost ControlWeak
01.

Operational Cost Control

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102199.75Bearish
  3. SMA 202206.05Bearish
  4. SMA 502233.19Bearish
  5. EMA 102200.80Bearish
  6. EMA 202205.34Bearish
  7. EMA 502223.62Bearish
  8. DEMA 102197.01Bullish
  9. DEMA 202194.80Bullish
  10. DEMA 502199.77Bearish
  11. TEMA 102196.30Bullish
  12. TEMA 202198.76Bearish
  13. TEMA 502182.21Bullish
  14. MACD-7.37Bullish
  15. ADX17.73Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI44.55Neutral
  3. CCI-44.38Neutral
  4. ROC 9-1.29Bearish
  5. ROC 14-0.10Bearish
  6. ROC 25-0.18Bearish
  7. Stoch K17.31Oversold
  8. Stoch D16.49Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2238.06Neutral
  3. BB Middle2206.05Neutral
  4. BB Lower2174.05Neutral
  5. ATR20.32Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI44.43Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102204.32Bearish
  3. SMA 202201.43Bearish
  4. SMA 502243.82Bearish
  5. EMA 102201.85Bearish
  6. EMA 202212.00Bearish
  7. EMA 502227.34Bearish
  8. DEMA 102195.17Bullish
  9. DEMA 202191.13Bullish
  10. DEMA 502236.68Bearish
  11. TEMA 102198.88Bearish
  12. TEMA 202188.82Bullish
  13. TEMA 502184.78Bullish
  14. MACD-14.68Bullish
  15. ADX23.18Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.36Neutral
  3. CCI-32.55Neutral
  4. ROC 9-0.10Bearish
  5. ROC 140.38Bullish
  6. ROC 25-4.72Bearish
  7. Stoch K30.13Neutral
  8. Stoch D27.89Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2230.99Neutral
  3. BB Middle2201.42Neutral
  4. BB Lower2171.86Neutral
  5. ATR30.16Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI58.92Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102201.44Bearish
  3. SMA 202245.27Bearish
  4. SMA 502244.30Bearish
  5. EMA 102212.50Bearish
  6. EMA 202227.58Bearish
  7. EMA 502183.49Bullish
  8. DEMA 102192.40Bullish
  9. DEMA 202216.95Bearish
  10. DEMA 502311.81Bearish
  11. TEMA 102190.23Bullish
  12. TEMA 202180.39Bullish
  13. TEMA 50N/AN/A
  14. MACD-10.65Bearish
  15. ADX27.43Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI45.18Neutral
  3. CCI-79.11Neutral
  4. ROC 9-1.10Bearish
  5. ROC 14-3.19Bearish
  6. ROC 25-1.36Bearish
  7. Stoch K13.54Oversold
  8. Stoch D16.65Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2349.03Neutral
  3. BB Middle2245.27Neutral
  4. BB Lower2141.51Neutral
  5. ATR53.00Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI47.20Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 102243.74Bearish
  3. SMA 202266.41Bearish
  4. SMA 502007.84Bullish
  5. SMA 1001880.82Bullish
  6. SMA 2001858.09Bullish
  7. EMA 102227.14Bearish
  8. EMA 202202.75Bearish
  9. EMA 502065.40Bullish
  10. EMA 1001951.68Bullish
  11. EMA 2001874.04Bullish
  12. DEMA 102220.65Bearish
  13. DEMA 202287.55Bearish
  14. DEMA 502243.19Bearish
  15. DEMA 1002087.46Bullish
  16. DEMA 2001965.55Bullish
  17. TEMA 102186.16Bullish
  18. TEMA 202249.91Bearish
  19. TEMA 502333.23Bearish
  20. TEMA 1002197.24Bullish
  21. TEMA 2002034.78Bullish
  22. MACD53.39Bearish
  23. ADX32.00Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.60Neutral
  3. CCI-102.63Oversold
  4. ROC 14-2.12Bearish
  5. ROC 2519.41Bullish
  6. Stoch K10.99Oversold
  7. Stoch D12.35Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2359.68Neutral
  3. BB Middle2266.42Neutral
  4. BB Lower2173.15Neutral
  5. ATR88.87Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.11Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201867.05Bullish
  3. SMA 501863.74Bullish
  4. EMA 201937.67Bullish
  5. EMA 501844.80Bullish
  6. DEMA 202067.54Bullish
  7. DEMA 501918.61Bullish
  8. TEMA 202174.87Bullish
  9. TEMA 501980.30Bullish
  10. MACD115.37Bullish
  11. ADX29.99Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.72Neutral
  3. CCI221.34Overbought
  4. ROC 1435.54Bullish
  5. ROC 2535.32Bullish
  6. Stoch K83.67Overbought
  7. Stoch D85.45Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2306.22Neutral
  3. BB Middle1867.05Neutral
  4. BB Lower1427.87Neutral
  5. ATR153.50High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI85.20Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61847.95Bullish
  3. SMA 121878.14Bullish
  4. SMA 241790.23Bullish
  5. EMA 61910.61Bullish
  6. EMA 121853.04Bullish
  7. EMA 241832.39Bullish
  8. DEMA 61992.55Bullish
  9. DEMA 121918.57Bullish
  10. DEMA 241788.32Bullish
  11. TEMA 62050.03Bullish
  12. TEMA 121965.79Bullish
  13. TEMA 24N/AN/A
  14. MACD-237.12Bullish
  15. ADX11.70Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.93Neutral
  3. CCI77.93Neutral
  4. ROC 2531.49Bullish
  5. ROC 50-31.25Bearish
  6. Stoch K56.77Neutral
  7. Stoch D56.36Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2154.68Overbought
  3. BB Middle1768.24Neutral
  4. BB Lower1381.79Neutral
  5. ATR294.64High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI70.72Neutral